{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:19:36Z","timestamp":1787501976240,"version":"build-2736575974"},"reference-count":145,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Inorganic Biochemistry"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.jinorgbio.2023.112150","type":"journal-article","created":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T01:51:39Z","timestamp":1675043499000},"page":"112150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Key regulators in the architecture of substrate access\/egress channels in mammalian cytochromes P450 governing flexibility in substrate oxyfunctionalization"],"prefix":"10.1016","volume":"241","author":[{"given":"Peter","family":"Hlavica","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinorgbio.2023.112150_bb0005","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.enzmictec.2004.07.018","article-title":"A selective review of bacterial forms of cytochrome P450 enzymes","volume":"36","author":"Lewis","year":"2005","journal-title":"Enzym. Microb. Technol."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0010","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s11101-006-9028-y","article-title":"Homology modelling of plant cytochrome P450s","volume":"5","author":"Rupasinghe","year":"2006","journal-title":"Phytochem. Rev."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0015","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.jinorgbio.2011.05.003","article-title":"Insect cytochromes P450: topology of structural elements predicted to govern catalytic versatility","volume":"105","author":"Hlavica","year":"2011","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0020","first-page":"205","article-title":"Evaluation of structural features in fungal cytochromes P450 predicted to rule catalytic diversification","volume":"2013","author":"Hlavica","year":"1834","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0025","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1016\/S0021-9258(20)82244-3","article-title":"The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature","volume":"239","author":"Omura","year":"1964","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0030","first-page":"361","article-title":"Cytochrome P450 and steroid hormone biosynthesis","volume":"3","author":"Bernhardt","year":"2007","journal-title":"Met. Ions Life Sci."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0035","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2174\/138920010791110881","article-title":"Oxidative biotransformation of fatty acids by cytochromes P450: predicted key structural elements orchestrating substrate specificity, regioselectivity and catalytic efficiency","volume":"11","author":"Hlavica","year":"2010","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0040","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.bbapap.2006.01.013","article-title":"Functional interaction of nitrogenous organic bases with cytochrome P450: a critical assessment and update of substrate features and predicted key active-site elements steering the access, binding and orientation of amines","volume":"1764","author":"Hlavica","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/03602530701836662","article-title":"Cytochrome P450: a structure-based summary of biotransformations using representative substrates","volume":"40","author":"Brown","year":"2008","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0050","series-title":"Cytochrome P450, Structure, Mechanism, and Biochemistry","first-page":"69","article-title":"Activation of molecular oxygen in cytochrome P450","author":"Denisov","year":"2015"},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0055","doi-asserted-by":"crossref","first-page":"7324","DOI":"10.1021\/jacs.8b03901","article-title":"Human cytochrome CYP17A1: the structural basis for compromised lyase activity with 17-hydroxyprogesterone","volume":"140","author":"Mak","year":"2018","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0060","series-title":"The Chemistry of Double-Bonded Functional Groups, Part 2","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1002\/0470857234.ch26","article-title":"N-oxidative transformation of C=N groups as means of toxification and detoxification","author":"Hlavica","year":"1997"},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0065","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.1111\/j.1432-1033.2004.04380.x","article-title":"Models and mechanisms of O-O bond activation by cytochrome P450. A critical assessment of the potential role of multiple active intermediates in oxidative catalysis","volume":"271","author":"Hlavica","year":"2004","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-319-16009-2_1","article-title":"Monooxygenase, peroxidase and peroxygenase pro-perties and reaction mechanisms of cytochrome P450 enzymes","volume":"851","author":"Hrycay","year":"2015","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0075","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/978-3-319-16009-2_2","article-title":"Oxidizing intermediates in P450 catalysis: a case for multiple oxidants","volume":"851","author":"Modi","year":"2015","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0080","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.bbagen.2006.07.017","article-title":"Cytochrome P450 systems \u2013 biological variations of electron transport chains","volume":"1770","author":"Hannemann","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0085","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0005-2728(00)00202-4","article-title":"Interactions between redox partners in various cytochrome P450 systems: functional and structural aspects","volume":"1460","author":"Lewis","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0090","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0162-0134(03)00152-1","article-title":"Functional interaction of cytochrome P450 with its redox partners: a critical assessment and update of the topology of predicted contact regions","volume":"96","author":"Hlavica","year":"2003","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0095","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/978-3-319-16009-2_10","article-title":"Mechanistic basis of electron transfer to cytochromes P450 by natural redox partners and artificial donor constructs","volume":"851","author":"Hlavica","year":"2015","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0100","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jmb.2004.07.009","article-title":"Structural evidence for direct hydride transfer from NADH to cytochrome P450nor","volume":"342","author":"Oshima","year":"2004","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0105","doi-asserted-by":"crossref","first-page":"594","DOI":"10.2174\/138920007781368881","article-title":"Control by substrate of the cytochrome P450-dependent redox machinery: mechanistic insights","volume":"8","author":"Hlavica","year":"2007","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0110","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.biotechadv.2008.10.001","article-title":"Assembly of non-natural electron transfer conduits in the cytochrome P450 system: a critical assessment and update of artificial redox constructs amenable to exploitation in biotechnological areas","volume":"27","author":"Hlavica","year":"2009","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0115","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jinorgbio.2016.11.025","article-title":"Challenges in assignment of allosteric effects in cytochrome P450-catalyzed substrate oxidations to structural dynamics in the hemoprotein architecture","volume":"167","author":"Hlavica","year":"2017","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0120","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/prot.22052","article-title":"MolAxis: efficient and accurate identification of channels in macromolecules","volume":"73","author":"Yaffe","year":"2008","journal-title":"Proteins"},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0125","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1758-2946-5-39","article-title":"Mole 2.0: advanced approach for analysis of biomacromolecular channels","volume":"5","author":"Sehnal","year":"2013","journal-title":"J. Cheminform."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0130","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1186\/1471-2105-7-316","article-title":"CAVER: a new tool to explore routes from protein clefts, pockets and cavities","volume":"7","author":"Petrek","year":"2006","journal-title":"BMC Bioinfor-matics"},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0135","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.bbagen.2006.07.005","article-title":"The ins and outs of cytochrome P450s","volume":"1770","author":"Cojocaru","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0140","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2174\/138920012798918462","article-title":"Multiple ligand-dependent routes from the active site of cytochrome P450 2C9","volume":"13","author":"Cojocaru","year":"2012","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0099408","article-title":"Ensemble generation and the influence of protein flexibility on geometric tunnel Pr\u00e4diktion in cytochrome P450 enzymes","volume":"9","author":"Kingsley","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0150","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1146\/annurev.pharmtox.45.120403.100010","article-title":"Cytochrome P450 activation of arylamines and heterocyclic amines","volume":"45","author":"Kim","year":"2005","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0155","series-title":"Cytochrome P450, Structure, Mechanism, and Biochemistry","first-page":"523","article-title":"Human cytochrome P450 enzymes","author":"Guengerich","year":"2015"},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0160","first-page":"696","article-title":"Access channels to the buried active site control substrate specificity in CYP1A P450 enzymes","volume":"2015","author":"Urban","year":"1850","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0165","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.bbagen.2006.08.005","article-title":"A combinatorial approach to substrate discrimination in the P450 CYP1A subfamily","volume":"1770","author":"Taly","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0170","first-page":"2852","article-title":"Molecular insights into the role of a distal F240A mutation that alters CYP1A1 activity towards persistent organic pollutants","volume":"2017","author":"Navratilova","year":"1861","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0175","doi-asserted-by":"crossref","first-page":"19201","DOI":"10.1074\/jbc.RA118.005588","article-title":"Structures of human cytochrome P450 1A1 with bergamottin and erlotinib reveal active-site modifications for binding of diverse ligands","volume":"293","author":"Bart","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0180","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jmgm.2016.06.006","article-title":"Prediction of three-dimensional structures and structural flexibilities of wild-type and mutant cytochrome P450 1A2 using molecular dynamics simulations","volume":"68","author":"Watanabe","year":"2016","journal-title":"J. Mol. Graph. Modell."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0185","doi-asserted-by":"crossref","first-page":"7293","DOI":"10.1074\/jbc.M709783200","article-title":"Cooperativity in oxidation reactions catalyzed by cytochrome P450 1A2. Highly cooperative pyrene hydroxylation and multiphasic kinetics of ligand binding","volume":"283","author":"Sohl","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0190","first-page":"291","article-title":"Is CYP1B1 involved in the metabolism of dioxins in the pig ?","volume":"2019","author":"Molcan","year":"1863","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0195","doi-asserted-by":"crossref","first-page":"745","DOI":"10.2174\/13892002113149990097","article-title":"Combining in silico protein stability calculations with structure-function relationships to explore the effect of poly- morphic variation on cytochrome P450 drug metabolism","volume":"14","author":"Arendse","year":"2013","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0200","doi-asserted-by":"crossref","first-page":"5640","DOI":"10.1074\/jbc.RA119.010727","article-title":"Structure of an ancestral mammalian family 1B1 cytochrome P450 with increased thermostability","volume":"295","author":"Bart","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0205","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/prot.22880","article-title":"Exploring coumarin egress channels in human cytochrome P450 2A6 by random acceleration and steered molecular dynamics simulations","volume":"79","author":"Li","year":"2011","journal-title":"Proteins"},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0210","doi-asserted-by":"crossref","first-page":"26576","DOI":"10.1074\/jbc.M112.372813","article-title":"Nicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone binding and access channel in human cytochrome P450 2A6 and 2A13 enzymes","volume":"287","author":"DeVore","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0215","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1124\/dmd.105.004200","article-title":"Possible pathway(s) of testosterone egress from the active site of cytochrome P450 2B1: a steered molecular dynamics simulation","volume":"33","author":"Li","year":"2005","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0220","doi-asserted-by":"crossref","first-page":"25678","DOI":"10.1074\/jbc.M109.032748","article-title":"Effect of conformational dynamics on substrate recognition and specificity as probed by the introduction of a de Novo disulfide bond into cytochrome P450 2B1","volume":"284","author":"Zhang","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0225","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.abb.2007.09.017","article-title":"Mapping of cytochrome P450 2B4 substrate binding sites by photolabile probe 3-azidiamantane: identification of putative substrate access regions","volume":"468","author":"Hodek","year":"2007","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0230","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.abb.2014.01.008","article-title":"The role of cytochrome P450 2B6 and 2B4 substrate access channel residues predicted based on crystal structures of the amlodipine complexes","volume":"545","author":"Jang","year":"2014","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0235","doi-asserted-by":"crossref","first-page":"7225","DOI":"10.1021\/bi300894z","article-title":"Conformational adaptation of human cytochrome P450 2B6 and rabbit cytochrome P450 2B4 revealed upon binding multiple amlodipine molecules","volume":"51","author":"Shah","year":"2012","journal-title":"Biochemistry"},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0240","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1021\/bi301567z","article-title":"Potent mechanism-based inactivation of cytochrome P450 2B4 by 9-ethynylphenanthrene: implications for allosteric modulation of cytochrome P450 catalysis","volume":"52","author":"Zhang","year":"2013","journal-title":"Biochemistry"},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0245","first-page":"1395","article-title":"Ordered chimerogenesis applied to CYP2B P450 enzymes","volume":"2016","author":"Lautier","year":"1860","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0250","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/sj.embor.7400420","article-title":"Do mammalian cytochrome P450s show multiple ligand access pathways and ligand channeling ?","volume":"6","author":"Schleinkofer","year":"2005","journal-title":"EMBO Rep."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0255","doi-asserted-by":"crossref","first-page":"9497","DOI":"10.1074\/jbc.M312516200","article-title":"Structure of human microsomal cytochrome P450 2C8. Evidence for a peripheral fatty acid binding site","volume":"279","author":"Schoch","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0260","doi-asserted-by":"crossref","first-page":"17227","DOI":"10.1074\/jbc.M802180200","article-title":"Determinants of cytochrome P450 2C8 substrate binding structures of complexes with montelukast, troglitazone, felodipine, and 9-cis-retinoic acid","volume":"283","author":"Schoch","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0265","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.biochi.2011.02.008","article-title":"Reduced catalytic activity of human CYP2C9 natural alleles for gliclazide: molecular dynamics simulation and docking studies","volume":"93","author":"Banu","year":"2011","journal-title":"Biochimie"},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0270","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1002152","article-title":"Structure and dynamics of the membrane-bound cytochrome P450 2C9","volume":"7","author":"Cojocaru","year":"2011","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0275","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/prot.20951","article-title":"Multiple molecular dynamics simulations of human P450 monooxygenase CYP2C9: the molecular basis of substrate binding and regioselectivity toward warfarin","volume":"64","author":"Seifert","year":"2006","journal-title":"Proteins"},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0280","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nature01862","article-title":"Crystal structure of human cytochrome P450 2C9 with bound warfarin","volume":"424","author":"Williams","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0285","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.bcp.2014.07.004","article-title":"CYP2C19 polymorphisms account for inter-individual variability of drug metabolism in cynomolgus macaques","volume":"91","author":"Uno","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0290","doi-asserted-by":"crossref","first-page":"12496","DOI":"10.1074\/jbc.271.21.12496","article-title":"Identification of residues 99, 220, and 221 of human cytochrome P450 2C19 as key determinants of omeprazole hydroxylase activity","volume":"271","author":"Ibeanu","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0295","doi-asserted-by":"crossref","first-page":"5092","DOI":"10.1074\/jbc.M114.627661","article-title":"Contributions of ionic interactions and protein dynamics to cytochrome P450 2D6 (CYP2D6) substrate and inhibitor binding","volume":"290","author":"Wang","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0300","doi-asserted-by":"crossref","first-page":"7614","DOI":"10.1074\/jbc.M511232200","article-title":"Crystal structure of human cytochrome P450 2D6","volume":"281","author":"Rowland","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0305","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1021\/acs.jcim.8b00080","article-title":"Molecular dynamics simulations reveal structural differences among allelic variants of membrane-anchored cytochrome P450 2D6","volume":"58","author":"Fischer","year":"2018","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0310","doi-asserted-by":"crossref","first-page":"16411","DOI":"10.1038\/s41598-019-52681-w","article-title":"Spontaneous ligand access events to membrane-bound cytochrome P450 2D6 sampled at atomic resolution","volume":"9","author":"Fischer","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0315","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/86d9f6df-7175-467c-a9ff-94eac53af128","article-title":"Investigation of indazole binding pathways in CYP2E1 by molecular dynamics simulations","volume":"7","author":"Shen","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0320","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/bip.22567","article-title":"Molecular basis of the recognition of arachidonic acid by cytochrome P450 2E1 along major access tunnel","volume":"103","author":"Cui","year":"2015","journal-title":"Biopolymers"},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0325","doi-asserted-by":"crossref","first-page":"33698","DOI":"10.1074\/jbc.M805999200","article-title":"Structures of human cytochrome P-450 2E1: insights into the binding of inhibitors and both small molecular weight and fatty acid substrates","volume":"283","author":"Porubsky","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0330","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.2174\/138920012802138606","article-title":"Negatively cooperative binding properties of human cytochrome P450 2E1 with monocyclic substrates","volume":"13","author":"Ping","year":"2012","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0335","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1074\/jbc.M707630200","article-title":"CYP2E1 substrate inhibition. Mechanistic interpretation through an effector site for monocyclic compounds","volume":"283","author":"Collom","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0340","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1002\/prot.21778","article-title":"Probing ligand binding modes of human cytochrome P450 2J2 by homology modeling, molecular dynamics simulation, and flexible molecular docking","volume":"71","author":"Li","year":"2008","journal-title":"Proteins"},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0345","doi-asserted-by":"crossref","first-page":"10237","DOI":"10.1021\/bi700876a","article-title":"Unusual regioselectivity and active site topology of human cytochrome P450 2J2","volume":"46","author":"Lafite","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0350","doi-asserted-by":"crossref","first-page":"13018","DOI":"10.1021\/jp810386z","article-title":"Theoretical characterization of substrate access\/exit channels in the human cytochrome P450 3A4 enzyme: involvement of phenylalanine residues in the gating mechanism","volume":"113","author":"Fishelovitch","year":"2009","journal-title":"J. Phys. Chem."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0355","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jmb.2008.03.065","article-title":"Structural analysis of CYP2R1in complex with vitamin D3","volume":"380","author":"Strushkevich","year":"2008","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0360","first-page":"1426","article-title":"Expression in yeast, new substrates, and construction of a first 3D model of human orphan cytochrome P450 2U1: interpretation of substrate hydroxylation regioselecti-vity from docking studies","volume":"2015","author":"Ducassou","year":"1850","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0365","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.1074\/jbc.RA117.000961","article-title":"Membrane-embedded substrate recognition by cytochrome P450 3A4","volume":"293","author":"Hackett","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0370","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.abb.2004.07.003","article-title":"Homotropic cooperativity of monomeric cyto-chrome P450 3A4 in a nanoscale native bilayer environment","volume":"430","author":"Baas","year":"2004","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0375","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0022-3565(24)39272-9","article-title":"Dual role of human cytochrome P450 3A4 residue Phe-304 in substrate specificity and cooperativity","volume":"293","author":"Domanski","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0380","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1021\/acs.biochem.5b00079","article-title":"Mechanism of drug-drug interactions mediated by human cytochrome P450 CYP 3A4 monomer","volume":"54","author":"Denisov","year":"2015","journal-title":"Biochemistry"},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0385","doi-asserted-by":"crossref","first-page":"10150","DOI":"10.1021\/bi010758a","article-title":"Phenylalanine and tryptophan scanning mutagenesis of CYP3A4 substrate recognition site residues and effect on substrate oxidation and cooperativity","volume":"40","author":"Domanski","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0390","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1006\/abbi.1997.0525","article-title":"Analysis of four residues within substrate recognition site 4 of human cytochrome P450 3A4: role of steroid hydroxylase activity and \u03b1-naphthoflavone stimulation","volume":"350","author":"Domanski","year":"1998","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0395","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1021\/acs.biochem.9b01001","article-title":"Dynamics and location of the allosteric midazolam site in cytochrome P450 3A4 in lipid nanodiscs","volume":"59","author":"Redhair","year":"2020","journal-title":"Biochemistry"},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0400","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0026-895X(24)12112-8","article-title":"Midazolam oxidation by cytochrome P450 3A4 and active-site mutants: an evaluation of multiple binding sites and of the metabolic pathway that leads to enzyme inactivation","volume":"61","author":"Khan","year":"2002","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0405","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1003714","article-title":"A multiscale approach to modelling drug metabolism by membrane-bound cytochrome P450 enzymes","volume":"10","author":"Lonsdale","year":"2014","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0410","doi-asserted-by":"crossref","first-page":"987","DOI":"10.3390\/ijms20040987","article-title":"Four major channels detected in the cytochrome P450 3A4: a step toward understanding its multispecificity","volume":"20","author":"Benkaidali","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0415","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1039\/C2DT31833D","article-title":"Understanding the mechanism of cytochrome P450 3A4: recent advances and remaining problems","volume":"42","author":"Sevrioukova","year":"2013","journal-title":"Dalton Trans."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0420","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1124\/dmd.106.014019","article-title":"Possible pathway(s) of metyrapone egress from the active site of cytochrome P450 3A4: a molecular dynamics simulation","volume":"35","author":"Li","year":"2007","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0425","doi-asserted-by":"crossref","first-page":"8015","DOI":"10.1074\/jbc.RA119.007928","article-title":"Active-site differences between substrate-free and ritonavir-bound cytochrome P450 (CYP)3A5 reveal plasticity differences between CYP3A5 and CYP3A4","volume":"294","author":"Hsu","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0430","doi-asserted-by":"crossref","first-page":"12536","DOI":"10.1021\/bi980895g","article-title":"Structure-function relationships of human liver cytochromes P450 3A: aflatoxin B1 metabolism as a probe","volume":"37","author":"Wang","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0435","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1080\/004982599238227","article-title":"Molecular modelling of CYP 4A subfamily members based on sequence homology with CYP102","volume":"29","author":"Lewis","year":"1999","journal-title":"Xenobiotica"},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0440","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.jmgm.2009.11.010","article-title":"Molecular modeling study on orphan human protein CYP4A22 for identification of potential ligand binding site","volume":"28","author":"Gajendrarao","year":"2010","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0445","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1002\/1873-3468.13489","article-title":"Functional characterization and mechanistic modeling of the human cytochrome P450 enzyme CYP4A22","volume":"593","author":"Durairaj","year":"2019","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0450","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1021\/acs.chemrestox.8b00353","article-title":"Glutamine-451 confers sensisivity to oxidative inhibition and heme-thiolate sulfenylation of cytochrome P450 4B1","volume":"32","author":"Albertolle","year":"2019","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0455","doi-asserted-by":"crossref","first-page":"42188","DOI":"10.1074\/jbc.M509220200","article-title":"Role of active site water molecules and substrate hydroxyl groups in oxygen activation by cytochrome P450 158A2. A new mechanism of proton transfer","volume":"280","author":"Zhao","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0460","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.abb.2005.07.003","article-title":"Oxygenation of polyunsaturated long chain fatty acids by recombinant CYP4F8 and CYP4F12 and catalytic importance of Tyr-125 and Gly-328 of CYP4F8","volume":"441","author":"Stark","year":"2005","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0465","doi-asserted-by":"crossref","first-page":"31459","DOI":"10.1074\/jbc.M103943200","article-title":"Membrane binding and substrate access merge in cytochrome P450 7A1, a key enzyme in degradation of cholesterol","volume":"276","author":"Nakayama","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0470","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/chem.201202627","article-title":"Structural and dynamic basis of human cytochrome P450 7B1: a survey of substrate selectivity and major active site access channels","volume":"19","author":"Cui","year":"2013","journal-title":"Chem. Eur. J."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0475","doi-asserted-by":"crossref","first-page":"10139","DOI":"10.1073\/pnas.1019441108","article-title":"Structural basis for pregnenolone biosynthesis by the mitochondrial monooxygenase system","volume":"108","author":"Strushkevich","year":"2011","journal-title":"Proc. Nat. Acad. Sci."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0480","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1210\/me.2012-1287","article-title":"Structural insights into aldosterone synthase substrate specificity and inhibition","volume":"27","author":"Strushkevich","year":"2013","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0485","first-page":"3996","article-title":"Recombinant CYP11B genes encode enzymes that can catalyze conversion of 11-deoxycortisol to cortisol, 18-hydroxy-cortisol, and 18-oxocortisol","volume":"83","author":"Mulatero","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0490","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1021\/acs.jcim.0c00447","article-title":"Comparative dynamics and functional mechanisms of the CYP17A1 tunnels regulated by ligand binding","volume":"60","author":"Xiao","year":"2020","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0495","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.jmb.2010.05.069","article-title":"Molecular modeling on inhibitor complexes and active-site dynamics of cytochrome P450 C17, a target for prostate cancer therapy","volume":"400","author":"Haider","year":"2010","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0500","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0960-0760(01)00172-8","article-title":"Comparison of the hamster and human adrenal P450c17 (17\u03b1-hydroxylase\/17,20-lyase) using site-directed mutagenesis and molecular modeling","volume":"80","author":"Mathieu","year":"2002","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0505","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1021\/ci400553w","article-title":"Molecular dynamic investigations of the mutational effects on structural characteristics and tunnel geometry in CYP17A1","volume":"53","author":"Cui","year":"2013","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0510","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1021\/acs.biochem.0c00460","article-title":"Dynamics and mechanism of binding of androstenedione to membrane-associated aromatase","volume":"59","author":"Paco","year":"2020","journal-title":"Biochemistry"},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0515","doi-asserted-by":"crossref","first-page":"5821","DOI":"10.1021\/bi400669h","article-title":"Structural basis for the functional roles of critical residues in human cytochrome P450 aromatase","volume":"52","author":"Lo","year":"2013","journal-title":"Biochemistry"},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0520","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1021\/ci300151h","article-title":"Influence of the membrane lipophilic environment on the structure and on the substrate access\/egress routes of the human aromatase enzyme. A computational study","volume":"52","author":"Sgrignani","year":"2012","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0525","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1046\/j.1432-1033.2001.01886.x","article-title":"Evaluation of the mechanism of aromatase cytochrome P450. A site-directed mutagenesis study","volume":"268","author":"Kao","year":"2001","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0530","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1042\/BCJ20190633","article-title":"Phosphorylation of human placental aromatase CYP19A1","volume":"476","author":"Ghosh","year":"2019","journal-title":"Biochem. J."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0535","article-title":"Motion and flexibility in human cytochrome P450 aromatase","volume":"7","author":"Jiang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0540","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/pro.5560040605","article-title":"A three-dimensional model of aromatase cytochrome P450","volume":"4","author":"Graham-Lorence","year":"1995","journal-title":"Protein Sci."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0545","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.steroids.2011.02.037","article-title":"Binding features of steroidal and nonsteroidal inhibitors","volume":"76","author":"Hong","year":"2011","journal-title":"Steroids"},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0550","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/bab.1613","article-title":"Working at the membrane interface: ligand-induced changes in dynamic conformation and oligomeric structure in human aromatase","volume":"65","author":"Di Nardo","year":"2018","journal-title":"Biotechnol. Appl. Biochem."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0555","doi-asserted-by":"crossref","first-page":"10613","DOI":"10.1074\/jbc.M111.323501","article-title":"Three-dimensional structure of steroid 21-hydroxylase (cytochrome P450 21A2) with two substrates reveals locations of disease-associated variants","volume":"287","author":"Zhao","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0560","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1002\/bit.27246","article-title":"Identification and circumvention of bottlenecks in CYP21A2-mediated premedrol production using recombinant Escherichia coli","volume":"117","author":"K\u00f6nig","year":"2020","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0565","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.abb.2006.11.030","article-title":"Generation of a homology model for the human cytochrome P450, CYP24A1, and the testing of putative substrate binding residues by site-directed mutagenesis and enzyme activity studies","volume":"460","author":"Masuda","year":"2007","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0570","doi-asserted-by":"crossref","first-page":"7702","DOI":"10.1021\/jm5009314","article-title":"Small-molecule inhibitors of 25-hydroxyvitamin D-24-hydroxylase (CYP24A1): synthesis and biological evaluation","volume":"57","author":"Ferla","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0575","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.abb.2006.11.018","article-title":"Hybrid homology modeling and mutational analysis of cytochrome P450C24A1 (CYP24A1) of the vitamin D pathway: insights into substrate specificity and membrane bound structure-function","volume":"460","author":"Annalora","year":"2007","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0580","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s00894-009-0571-5","article-title":"Probing possible egress channels for multiple ligands in human CYP3A4: a molecular modeling study","volume":"16","author":"Krishnamoorthy","year":"2010","journal-title":"J. Mol. Model."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0585","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1529\/biophysj.105.069369","article-title":"Structural motif-based homology modeling of CYP27A1 and site-directed mutational analyses affecting vitamin D hydroxylation","volume":"90","author":"Prosser","year":"2006","journal-title":"Biophys. J."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0590","doi-asserted-by":"crossref","first-page":"9546","DOI":"10.1073\/pnas.0803717105","article-title":"Crystal structures of substrate-bound and substrate-free cytochrome P450 46A1, the principal cholesterol hydroxylase in the brain","volume":"105","author":"Mast","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0595","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1074\/jbc.M113.532846","article-title":"Pharmacologic stimulation of cytochrome P450 46A1 and cerebral cholesterol turnover in mice","volume":"289","author":"Mast","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0600","doi-asserted-by":"crossref","first-page":"4613","DOI":"10.1074\/jbc.M112.438754","article-title":"Binding of a cyano- and fluoro-containing drug bicalutamide to cytochrome P450 46A1. Unusual features and spectral response","volume":"288","author":"Mast","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0605","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1124\/mol.113.085902","article-title":"Antifungal azoles: structural insights into undesired tight binding to cholesterol-metabolizing CYP46A1","volume":"84","author":"Mast","year":"2013","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0610","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.bbagen.2015.10.015","article-title":"Ligand tunnels in T. brucei and human CYP51: insights for parasite-specific drug design","volume":"1860","author":"Yu","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0615","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.jmb.2010.01.075","article-title":"Structural basis of human CYP51 inhibition by antifungal azoles","volume":"397","author":"Strushkevich","year":"2010","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0620","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.1021\/ci500556k","article-title":"Structural insight into the unique binding properties of pyridylethanol(phenylethyl)amine inhibitor in human CYP51","volume":"54","author":"Zelenko","year":"2014","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0625","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1472-6807-10-34","article-title":"Prediction and analysis of the modular structure of cytochrome P450 monooxygenases","volume":"10","author":"Sirim","year":"2010","journal-title":"BMC Struct. Biol."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0630","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1471-2091-10-27","article-title":"The cytochrome P450 engineering database: integration of biochemical properties","volume":"10","author":"Sirim","year":"2009","journal-title":"BMC Biochem."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0635","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1107\/S0021889892009944","article-title":"PROCHECK: a program to check the stereochemical quality of protein structures","volume":"26","author":"Laskowski","year":"1993","journal-title":"J. Appl. Crystallogr."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0640","doi-asserted-by":"crossref","first-page":"684","DOI":"10.2174\/138920011796504554","article-title":"An expanded, unified substrate recognition site map for mammalian cytochrome P450s: analysis of molecular interactions between 15 mammalian isoforms and 868 substrates","volume":"12","author":"Zawaira","year":"2011","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0645","doi-asserted-by":"crossref","first-page":"8542","DOI":"10.1021\/ja4003525","article-title":"Characterizing the membrane-bound state of cytochrome P450 3A4: structure, depth of insertion, and orientation","volume":"135","author":"Baylon","year":"2013","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0650","doi-asserted-by":"crossref","first-page":"1700044","DOI":"10.1002\/minf.201700044","article-title":"The cytochrome P450 3A4 has three major conformations: new clues to drug recognition by this promiscuous enzyme","volume":"36","author":"Benkaidali","year":"2017","journal-title":"Mol. Inf."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0655","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/bab.1074","article-title":"Conformational diversity and ligand tunnels of mammalian cytochrome P450s","volume":"60","author":"Yu","year":"2013","journal-title":"Biotechnol. Appl. Biochem."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0660","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1089\/ars.2010.3109","article-title":"Conformational plasticity and structure\/function relationships in cytochromes P450","volume":"13","author":"Pochapsky","year":"2010","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0665","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jinorgbio.2018.03.002","article-title":"Membrane-attached mammalian cytochrome P450: an overview of the membrane\u2019s effects on structure, drug binding, and interactions with redox partners","volume":"183","author":"Srejber","year":"2018","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0670","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1021\/ci500645k","article-title":"Effect of cholesterol on the structure of membrane-attached cytochrome P450 3A4","volume":"55","author":"Navratilova","year":"2015","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0675","first-page":"2013","article-title":"Structural features and dynamic investigations of the membrane-bound cytochrome P450 17A1","volume":"2015","author":"Cui","year":"1848","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0680","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1517\/17425250903431040","article-title":"Engineering cytochrome P450 biocatalysts for biotechnology, medicine and bioremediation","volume":"6","author":"Kumar","year":"2010","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0685","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.1021\/acs.jcim.1c00558","article-title":"F\/G region rigidity is inversely correlated to substrate promiscuity of human CYP isoforms involved in metabolism","volume":"61","author":"Becker","year":"2021","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0690","doi-asserted-by":"crossref","first-page":"19569","DOI":"10.1074\/jbc.M500158200","article-title":"Directed evolution of mammalian cytochrome P450 2B1. Mutations outside of the active site enhance the metabolism of several substrates, including the anticancer prodrugs cyclophosphamide and ifos-famide","volume":"280","author":"Kumar","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0695","doi-asserted-by":"crossref","first-page":"41090","DOI":"10.1074\/jbc.M508182200","article-title":"Expansion of substrate specificity of cytochrome P450 2A6 by random and site-directed mutagenesis","volume":"280","author":"Wu","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0700","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/cbdv.200490166","article-title":"Biosynthesis of new indigoid inhibitors of protein kinases using recombinant cytochrome P450 2A6","volume":"2","author":"Wu","year":"2005","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0705","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1016\/j.bios.2004.11.023","article-title":"Cytochrome P450 biosensors \u2013 a review","volume":"20","author":"Bistolas","year":"2005","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0710","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0006-291X(03)01439-6","article-title":"Generation of 2,3,7,8-TCDD-metabolizing enzyme by modifying rat CYP1A1 through site-directed mutagenesis","volume":"308","author":"Shinkyo","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0715","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.649273","article-title":"Reductive cytochrome P450 reactions and their potential role in bioremediation","volume":"12","author":"Behrendorff","year":"2021","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0720","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1006\/bbrc.1998.9084","article-title":"Marked enhancement in the reductive dehalogenation of hexachloroethane by a Thr319Ala mutation of cytochrome P450 1A2","volume":"249","author":"Yanagita","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jinorgbio.2023.112150_bb0725","doi-asserted-by":"crossref","first-page":"17082","DOI":"10.1074\/jbc.R113.452805","article-title":"Structural diversity of eukaryotic membrane cytochrome P450s","volume":"288","author":"Johnson","year":"2013","journal-title":"J. Biol. Chem."}],"container-title":["Journal of Inorganic Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0162013423000326?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0162013423000326?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T15:09:31Z","timestamp":1758985771000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0162013423000326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":145,"alternative-id":["S0162013423000326"],"URL":"https:\/\/doi.org\/10.1016\/j.jinorgbio.2023.112150","relation":{},"ISSN":["0162-0134"],"issn-type":[{"value":"0162-0134","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Key regulators in the architecture of substrate access\/egress channels in mammalian cytochromes P450 governing flexibility in substrate oxyfunctionalization","name":"articletitle","label":"Article Title"},{"value":"Journal of Inorganic Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinorgbio.2023.112150","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112150"}}